Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep 11;11(9):e7868.
doi: 10.1002/ccr3.7868. eCollection 2023 Sep.

Gastric adenocarcinoma complicated by an intra-abdominal abscess: A case report

Zubir S Rentiya  1   2 , Carlo Kristian Chu Carredo  3 , Oluwasayo Owolabi  4 , Pugazhendi Inban  5 , Faiza Arslan  6 , Victor Ameh Odoma  7 , Abiodun Adegbite  8 , Maya Ann Francis  9 , Isioma R Okobia  10 , Taha Sajjad  11 , Aadil Mahmood Khan  12 , Anasonye Emmanuel Kelechi  13
Affiliations
Case Reports

Gastric adenocarcinoma complicated by an intra-abdominal abscess: A case report

Zubir S Rentiya et al. Clin Case Rep. .

Abstract

Perforated gastric adenocarcinoma is a rare and challenging complication of gastric cancer, which can lead to intra-abdominal abscesses and other complications. Management of perforated gastric adenocarcinoma with an intra-abdominal abscess requires a multidisciplinary approach, including empiric antibiotic therapy and fluid resuscitation, partial gastrectomy with Roux-en-Y reconstruction, and image-guided drainage. This case report highlights the complex and challenging nature of managing perforated gastric adenocarcinoma with intra-abdominal abscesses. Prompt recognition and timely intervention are essential for favorable outcomes. Postoperative care and close follow-up are also important.

Keywords: Intra‐abdominal abscesses; gastric adenocarcinoma; human epidermal growth factor receptor 2 (HER2); image‐guided drainage; neoadjuvant chemotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
Macroscopic view of a large ulcerated and malignant appearing mass in the gastric body extending into the antrum and pylorus, approximately 10 cm from the gastroesophageal junction.
FIGURE 2
FIGURE 2
Ultrasound image showing a hypoechoic heterogeneous mass [arrow] in the gastric body and antrum region invading the muscularis propria and serosa, with no apparent invasion of adjacent structures. Additionally, two enlarged adjacent lymph nodes are observed [arrow].
FIGURE 3
FIGURE 3
(A) Small bowel perforation involving the anterior aspect of the proximal jejunum [arrow] and (B) large luminal defect at the lesser curvature of the stomach [arrow].
FIGURE 4
FIGURE 4
Left hepatic lobe hypoattenuating lesion surrounding the intrahepatic extension of the peri‐gastric fluid gas‐containing accumulation [arrow].
See this image and copyright information in PMC

References

    1. Melloni M, Bernardi D, Asti E, Bonavina L. Perforated gastric cancer: a systematic review. J Laparoendosc Adv Surg Tech A. 2020;30(2):156‐162. - PubMed
    1. Chiu CF, Yang HR, Yang MD, Chen TH. Surgical management and outcomes of gastric cancer perforation: a population‐based study. J Chin Med Assoc. 2019;82(8):661‐666. doi: 10.1097/JCMA.0000000000000112 - DOI
    1. Li Y, Zhong Y, Xu Q, Zhu Z, Tian Y. Prognostic significance of signet ring cells in gastric cancer: the higher proportion, The Better Survival. Front Oncol. 2021;11:713587. - PMC - PubMed
    1. Yu H, Xu L, Yin S, et al. Risk factors and prognostic impact of postoperative complications in patients with advanced gastric cancer receiving Neoadjuvant chemotherapy. Curr Oncol. 2022;29(9):6496‐6507. - PMC - PubMed
    1. Hyung WJ, Yang H‐K, Han SU, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi‐center phase II clinical trial, KLASS 03. Gastric Cancer. 2020;23(2):321‐329. doi: 10.1007/s10120-019-00999-6 - DOI - PubMed

Publication types